Ocular Hypertension Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 353287|Published date: 19 December, 2024
Obsessive-Compulsive Disorder Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 200557|Published date: 19 December, 2024
Noonan Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 840905|Published date: 19 December, 2024
Non-Melanoma Skin Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 518219|Published date: 18 December, 2024
Non-Hodgkin’s Lymphoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 145046|Published date: 18 December, 2024
Nocturia Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 522951|Published date: 18 December, 2024
Neurotrophic Keratitis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 788195|Published date: 18 December, 2024
Neuropathic Ocular Pain Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 113931|Published date: 18 December, 2024
Neuromyelitis Optica Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 920607|Published date: 16 December, 2024
Neuroendocrine Tumors Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 213676|Published date: 16 December, 2024
Netherton Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 432850|Published date: 16 December, 2024
Nerve Entrapment Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 501985|Published date: 16 December, 2024